NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.600
-0.060 (-3.61%)
At close: Mar 24, 2026, 4:00 PM EDT
1.590
-0.010 (-0.63%)
After-hours: Mar 24, 2026, 4:00 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $6.66 million as of March 24, 2026. Its market cap has increased by 90.26% in one year.
Market Cap
6.66M
Enterprise Value
-25.07M
1-Year Change
90.26%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $6.66M, a decrease of -98.70%. That is a compound annual growth rate of -40.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 6.90M | -54.00% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 7.51M |
| Xenetic Biosciences | 7.47M |
| Evogene | 7.38M |
| PharmaCyte Biotech | 7.37M |
| Alaunos Therapeutics | 7.19M |
| Alzamend Neuro | 6.96M |
| Addex Therapeutics | 6.91M |
| GridAI Technologies | 6.89M |